 After receiving study drug for up to 6 cycles, you will have surgery to remove the tumor as part of the standard of care for the disease. You will be given a separate consent form that describes this procedure and its risks. During the surgery, some of the tissue that is removed will be collected to check the status of the disease and for biomarker, PGt, and proteomic testing. After the surgery, you may be called by the study doctor to ask how you are doing. This call should last about 10 minutes. 